The Bangalore District Druggists and Chemists Association (BDCDA) has raised concerns about the growing proliferation of anti-competitive and non-compliant pharmaceutical advertising campaigns being ...

The Drugs Consultative Committee (DCC) has given its nod for the central government to go ahead with amendment of certain forms under the Drugs Rules, 1945 to enable industry to apply for ...

With representatives from over 100 countries and 700 Indian companies expected at iPHEX-2025 in New Delhi, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has formally invited the ...

The Indian pharmaceutical industry is currently navigating a challenging landscape shaped by US pricing reforms and Europe's increasing reliance on HTA (Health Technology Assessment) frameworks. India ...

Imports of bulk drugs and intermediates to India have seen a decline for the second consecutive month in FY26, and a cumulative decline for the first two months of the fiscal year. The imports ...

Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...

EMA & HMA issue recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins: Amsterdam, The Netherlands Monday, July 7, 2025, 09:00 Hrs [IST] The Euro ...

Shardul Nautiyal, Mumbai Saturday, July 5, 2025, 08:00 Hrs [IST] ...

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has reported that India's pharmaceutical export continued its growth trajectory with USD 2,475.70 million in May 2025, cumulating to ...

The Union government's substantial and commendable support for the Indian pharmaceutical industry, particularly for the MSME sector, is evident. T. Revichandran, vice-president of IDMA South Region, ...

The Drugs Consultative Committee (DCC) has recommended to the central drug regulator to communicate with the state and Union Territory (UT) drug controllers on standard implementation of the ...

Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...